14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CAPR ranks #13938 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Capricor Therapeutics Stock Forecast NASDAQ:CAPR

$3.87 (1.31%)

Volume: 131k

Closed: Oct 25, 2021

Hollow Logo Score: -3.099

Capricor Therapeutics Stock Forecast

$3.87 (1.31%)

Volume: 131k

Closed: Oct 25, 2021

Score Hollow Logo -3.099

Capricor Therapeutics Stock Price (Quote) NASDAQ:CAPR

$3.87 ( 1.31% ) Monday, 25th Oct 2021

Range Low Price High Price Comment
30 days $3.62 $4.94 Monday, 25th Oct 2021 CAPR stock ended at $3.87. This is 1.31% more than the trading day before Friday, 22nd Oct 2021. During the day the stock fluctuated 5.11% from a day low at $3.72 to a day high of $3.91.
90 days $3.62 $5.85
52 weeks $3.13 $8.40

Historical Capricor Therapeutics prices

Date Open High Low Close Volume
2021-10-25 $3.82 $3.91 $3.72 $3.87 131 346
2021-10-22 $3.96 $3.96 $3.78 $3.82 157 050
2021-10-21 $4.03 $4.06 $3.94 $3.99 81 600
2021-10-20 $3.98 $4.08 $3.91 $4.03 101 348
2021-10-19 $3.82 $4.04 $3.82 $3.96 167 562
2021-10-18 $3.95 $3.95 $3.86 $3.89 132 008
2021-10-15 $4.11 $4.17 $3.96 $3.96 201 913
2021-10-14 $4.15 $4.24 $4.10 $4.16 167 308
2021-10-13 $4.03 $4.16 $3.97 $4.12 160 680
2021-10-12 $4.12 $4.16 $3.96 $3.98 219 095
2021-10-11 $3.94 $4.07 $3.77 $4.07 458 342
2021-10-08 $3.69 $3.76 $3.62 $3.73 122 810
2021-10-07 $3.76 $3.77 $3.64 $3.68 225 059
2021-10-06 $3.77 $3.80 $3.64 $3.68 243 742
2021-10-05 $3.83 $3.93 $3.74 $3.84 289 387
2021-10-04 $3.92 $3.96 $3.80 $3.82 367 486
2021-10-01 $4.05 $4.06 $3.86 $3.97 288 105
2021-09-30 $3.88 $4.09 $3.87 $4.02 349 121
2021-09-29 $4.22 $4.22 $3.82 $3.88 873 256
2021-09-28 $4.34 $4.44 $4.13 $4.26 1 056 643
2021-09-27 $4.81 $4.94 $4.46 $4.48 1 476 685
2021-09-24 $5.83 $5.85 $4.98 $5.23 27 167 337
2021-09-23 $4.95 $5.25 $4.71 $5.02 564 846
2021-09-22 $4.80 $4.99 $4.80 $4.86 136 010
2021-09-21 $4.66 $4.95 $4.41 $4.79 444 620
2021-09-20 $4.73 $5.09 $4.52 $4.69 391 632
2021-09-17 $4.75 $5.03 $4.70 $5.03 255 950
2021-09-16 $4.40 $4.75 $4.22 $4.73 196 863
2021-09-15 $4.50 $4.52 $4.38 $4.45 182 766
2021-09-14 $4.80 $4.80 $4.46 $4.53 206 984
2021-09-13 $4.94 $4.94 $4.73 $4.77 136 241
2021-09-10 $5.00 $5.13 $4.85 $4.90 188 274
2021-09-09 $4.90 $5.13 $4.88 $5.01 125 587
2021-09-08 $4.83 $4.95 $4.76 $4.87 81 273
2021-09-07 $5.09 $5.17 $4.81 $4.88 126 245
2021-09-03 $5.00 $5.32 $4.80 $5.02 392 951
2021-09-02 $4.74 $4.97 $4.72 $4.88 200 112
2021-09-01 $4.98 $5.05 $4.56 $4.62 264 412
2021-08-31 $4.37 $5.15 $4.25 $5.01 572 110
2021-08-30 $4.16 $4.39 $4.07 $4.32 270 612
2021-08-27 $4.25 $4.34 $4.16 $4.19 129 080
2021-08-26 $4.32 $4.41 $4.09 $4.22 134 525
2021-08-25 $4.16 $4.43 $4.12 $4.28 206 405
2021-08-24 $4.03 $4.24 $4.01 $4.12 112 517
2021-08-23 $3.86 $4.11 $3.86 $4.04 130 729
2021-08-20 $3.84 $3.95 $3.80 $3.87 94 965
2021-08-19 $3.92 $4.01 $3.79 $3.80 90 483
2021-08-18 $3.95 $4.13 $3.85 $3.93 220 795
2021-08-17 $3.99 $4.21 $3.91 $3.97 141 143
2021-08-16 $3.98 $4.28 $3.97 $4.02 250 759

About Capricor Therapeutics

Capricor Therapeutics Capricor Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company’s development stage drug candidates for cardiovascular diseases include CAP-1002 and enderitide, which are in Phase II clinical trials, as well as CAP-1001, which has completed Phase I clinical trial; and CU-NP and CSps. It is also developing E... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT